Trichosporon asahii late onset sepsis in an extremely low birth weight infant

Maria Catalina Vaz Ferreira, Juan Pablo Gesuele

Abstract


We describe a case of Trichosporon asahii late-onset sepsis in an extremely low birth weight infant from our neonatal intensive care unit. The baby presented early neutropenia and received therapy with granulocyte colony-stimulating factor. At day of life 8 he showed clinical signs of sepsis. Forty-eight hours after beginning of symptoms, blood culture developed T. asahii. Baby responded to treatment with liposomal amphotericin B. The aim of this report is to discuss a case of late onset sepsis in an immuno-compromised patient due to an unusual pathogen, with variable or intrinsic resistance to the most commonly used antifungal therapies. Appropriate use of antifungal in this vulnerable population is of pivotal importance for both treatment and prevention of infection.


Keywords


late onset sepsis; Trichosporon asahii; extremely low birth weight infant

Full Text:

PDF

References


Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11(2):142-151.

Basu S, Tilak R, Kumar A. Multidrug-resistant Trichosporon: an unusual fungal sepsis in preterm neonates. Pathog Glob Health 2015; 109(4):202-206.

Ozkaya-Parlakay A, Karadag-Oncel E, Cengiz AB, et al. Trichosporon asahii sepsis in a patient with pediatric malignancy. J Microbiol Immunol Infect 2016; 49(1):146-149.

Arendrup MC, Boekhout T, Akova M, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 2014; 20(Suppl. 3):76-98.

Alzate Atehortuaa MA, Garzón J, Valderrama S, Zhong A. Tricosporonosis en un paciente con leucemia aguda. Acta Colomb Cuid Intensivo 2017; 17(1):68-75.

Castagnola E, Dufour C. Role of G-CSF and GM-CSF in the management of infections in preterm newborns: an update. Early Hum Dev 2014; 90(Suppl. 2):S15-S17.

Aktas D‚ Demirel B, Gursoy T, Ovali F. A randomized case-controlled study of recombinant human granulocyte colony stimulating factor for the treatment of sepsis in preterm neutropenic infants. Pediatr Neonatol 2015; 56(3):171-175.

Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect 2012; 64(1):68-75.

Puia-Dumitrescu M, Smith PB. Antifungal drugs in newborns and children. Pediatr Clin N Am 2017; 64(6):1389-1402.




DOI: http://dx.doi.org/10.22551/2018.18.0501.10119

Copyright (c) 2018 Maria Catalina Vaz Ferreira, Juan Pablo Gesuele

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

ISSN: 2360-6975